Drug-related problems and quality of life in arthritis and low back pain sufferers

被引:28
作者
Ernst, ME
Iyer, SS
Doucette, WR
机构
[1] Univ Iowa, Dept Family Med, Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Pharm, Div Clin & Adm Pharm, Iowa City, IA 52242 USA
关键词
drug-related problems; quality of life; arthritis; pharmacists;
D O I
10.1046/j.1524-4733.2003.00202.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: The objective of this study was to determine the relationship between drug-related problems (DRPs) and health-related quality-of-life (HRQoL) in ambulatory, community-dwelling patients with musculoskeletal disorders. Methods: A 12-month, prospective, observational study was conducted in 12 independent community pharmacies in eastern Iowa. Ambulatory patients with self-reported diagnoses of osteoarthritis, rheumatoid arthritis, or low back pain were invited to participate. During quarterly visits to the pharmacy, patients used touch-screen computers to fill out the Short Form-36 (SF-36) general health survey. Using the results of these point-of-service health status assessments, community pharmacists interviewed patients to assess for DRPs. To examine the influences of different DRP characteristics on HRQoL and controlling for potential confounders, both univariate and multivariate analyses were performed using the change in physical component summary (PCS) score and mental component summary (MCS) score of the SF-36 from baseline to 12 months as the dependent variables. In each regression, the independent variables were those significant variables from the univariate analyses, as well as the types of DRPs and their outcomes. Results: A total of 461 patients were enrolled in the study. Through 12 months, 926 cumulative DRPs were identified. Overall regression models were significant for the PCS and MCS scores, respectively. Two types of DRPs showed significant negative associations with change in PCS: wrong drug and needs additional drug therapy. One type of DRP showed significant negative association with change in MCS: needs additional drug therapy. Resolution or improvement in DRPs showed a significant positive correlation with change in MCS but not PCS. Conclusions: Two DRPs, needs additional drug therapy and wrong drug, are associated with reduced self-reported physical health in arthritis and low back pain, while the DRP needs additional drug therapy is also associated with reduced self-reported mental health. Resolution of DRPs is associated with improvement in mental health in this cohort.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 42 条
[1]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[2]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[3]   Explicit criteria for determining potentially inappropriate medication use by the elderly - An update [J].
Beers, MH .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) :1531-1536
[4]   To Err Is Human [J].
Bootman, JL .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3189-3189
[5]   Impact of osteoarthritis and analgesic treatment on quality of life of an elderly population [J].
Briggs, A ;
Scott, E ;
Steele, K .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (11) :1154-1159
[6]   Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. [J].
Buxton, J ;
White, M ;
Osoba, D .
QUALITY OF LIFE RESEARCH, 1998, 7 (06) :513-519
[7]   Measuring quality of life - Are quality of life measures patient centred? [J].
Carr, AJ ;
Higginson, IJ .
BRITISH MEDICAL JOURNAL, 2001, 322 (7298) :1357-1360
[8]  
Carter BL, 1997, PHARMACOTHERAPY, V17, P1274
[9]   Interpreting the findings of the IMPROVE study [J].
Carter, BL ;
Malone, DC ;
Billups, SJ ;
Valuck, RJ ;
Barnette, DJ ;
Sintek, CD ;
Ellis, S ;
Covey, D ;
Mason, B ;
Jue, S ;
Carmichael, J ;
Guthrie, K ;
Dombrowski, R ;
Geraets, DR ;
Amato, M .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (14) :1330-1337
[10]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P349